Telehealth model versus in-person standard care for persons with type 1 diabetes treated with multiple daily injections: an open-label randomized controlled trial

Overview of attention for article published in Frontiers in endocrinology, June 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 6,702 followers.

RT @elisendacb: 🔝🔝🔝

RT @SilBallesta: 📣 Avantatges de la #telemedicina en el maneig crònic de pacients amb diabetis tipus 1 #T1D 📣 @DrJchillaron @LlauradoGemma…

RT @SilBallesta: 📣 Avantatges de la #telemedicina en el maneig crònic de pacients amb diabetis tipus 1 #T1D 📣 @DrJchillaron @LlauradoGemma…

🔝🔝🔝

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.